Where does AbClonal Science, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AbClonal Science, Inc. ranks #15,078 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AbClonal Science, Inc. hold?

AbClonal Science, Inc. holds 19 US utility patents granted between 2020 and 2025, spanning 8 technology areas.

What is AbClonal Science, Inc.'s Innovation Score?

AbClonal Science, Inc. has an Innovation Score of 42.0 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is AbClonal Science, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for AbClonal Science, Inc..

What does claim depth mean for AbClonal Science, Inc.'s patents?

AbClonal Science, Inc.'s patents average 8.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AbClonal Science, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

AbClonal Science, Inc.

Q: What technology areas does AbClonal Science, Inc. focus on?

AbClonal Science, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 18 patents, ranking #606 of 4,144 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 8 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abclonal ranks #15,078 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 8 technology areas.

#15,078
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.0/100): 8.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15078 · US Corporation #15,078 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,078/49,997
PHOTO-FINISH Abu Dhabi National Oil
CPC-NARROW C12N · 8 areas
INNOV-PAR 42.0/100
CLAIMS-PAR 8.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Abu Dhabi National Oil Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abclonal’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (25%) Velocity 16.7 pts (40%) Breadth 10.0 pts (24%) Claim depth 5.0 pts (12%)

Qualcomm Incorporated · highest

85
AbClonal Science · this assignee

42
3D Lighting… · lowest

7

What this shows Abclonal's Innovation Score is 42.0/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abclonal?

Each dot is one of Abclonal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abclonal’s own 8.4 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Abclonal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abclonal's grants concentrate

AbClonal Science, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 94.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2020. By volume, Abclonal sits between Asymchem Laboratories (TIANJIN) Co., Ltd. and Ackley Machine Corporation.

Abclonal's three-year grant acceleration

AbClonal Science, Inc. shows 10 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Asymchem Laborato…

19
ATC Logistics &

19
Aviacomm

19
AVL Test Systems

19
Abu Dhabi Nationa…

19
Accelerated Syste…

19
Achaemenid

19
Ackley Machine

19
Abclonal Science ◀

19

What this shows AbClonal holds 19 patents at rank #15,106, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AbClonal

By rank, the assignees closest to #15,106 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in AbClonal's primary technology class.

Abclonal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

AbClonal Science, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	5.3%
2021	3	15.8%
2022	1	5.3%
2023	8	42.1%
2024	1	5.3%
2025partial year	5	26.3%

Which technologies does AbClonal Science, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

C12Y - Enzymes 15

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 13

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C07K - Peptides 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AbClonal Science, Inc.'s patent record in context - here's where to go next.

AbClonal Science, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 94.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #15,078 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AbClonal Science, Inc. against Asymchem Laboratories (TIANJIN) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.